e-learning
resources
London 2016
Tuesday, 06.09.2016
Non-inflammatory COPD monitoring
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In active and former smokers with CT detected emphysema but without airway obstruction, the presence of an abnormal DLco is associated with a worse clinical presentation
Jessica Gonzalez Gutierrez (Mutilva Baja (Pamplona), Spain), Jessica Gonzalez Gutierrez, Marta Marin Oto, Arantza Campo, Javier Zulueta, Ana Belen Alcaide, Juan Bertó, Juan Pablo De Torres
Source:
International Congress 2016 – Non-inflammatory COPD monitoring
Session:
Non-inflammatory COPD monitoring
Session type:
Oral Presentation
Number:
3522
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jessica Gonzalez Gutierrez (Mutilva Baja (Pamplona), Spain), Jessica Gonzalez Gutierrez, Marta Marin Oto, Arantza Campo, Javier Zulueta, Ana Belen Alcaide, Juan Bertó, Juan Pablo De Torres. In active and former smokers with CT detected emphysema but without airway obstruction, the presence of an abnormal DLco is associated with a worse clinical presentation. Eur Respir J 2016; 48: Suppl. 60, 3522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Prevalence of abnormal lung volumes, DLCO and chest HRCT in smokers with normal spirometry
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Small airway function in smokers without airway obstruction
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
Eosinophilic versus non-eosinophilic COPD cannot be distinguished by lung function nor CT determined emphysema or airway remodelling
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland
Source: Eur Respir J 2010; 36: 1259-1269
Year: 2010
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
Source: Eur Respir J 2004; 23: 464-476
Year: 2004
Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Functional status in high and low risk patient with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013
Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity
Source: Eur Respir J 2015; 46: 1589-1597
Year: 2015
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Source: Annual Congress 2013 –COPD treatment
Year: 2013
No increase in the prevalence of COPD in two decades
Source: Eur Respir J 2010; 36: 766-773
Year: 2010
Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept